ClinicalTrialsFinder

Christchurch Hospital. /ID# 201650

Christchurch, Canterbury, New Zealand

1 recruiting

Showing 1–1 of 1 trials

Recruiting
Phase 2

A Study of Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)
AbbVie110 enrolled31 locationsNCT02966756